Cell culture device and cell culture method

A cell culture device with a fibronectin-coated hydrophilic polymer layer addresses the challenge of capturing and culturing low-abundance cancer cells, improving adhesion and culture efficiency for drug testing and disease research.

JP7580076B2Active Publication Date: 2024-11-11SUMITOMO RUBBER INDUSTRIES LTD +1
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
JP2019010399
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2019-01-24
Publication Date
2024-11-11
Estimated Expiration
2039-01-24

AI Technical Summary

Technical Problem

Existing technologies face challenges in capturing and culturing cancer cells, particularly those that do not express EpCAM, due to their low abundance in blood and difficulties in adhesion and proliferation.

Method used

A cell culture device with a hydrophilic polymer layer coated with fibronectin is used to enhance the adhesion and culture of cancer cells, including those that do not express EpCAM, by forming a hydrophilic polymer layer on the device surface and adsorbing fibronectin to improve cell capture and culture efficiency.

Benefits of technology

The device significantly enhances the capture and culture of cancer cells, allowing for effective drug efficacy testing and disease mechanism elucidation by promoting cell adhesion and differentiation, while reducing non-specific cell capture.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007580076000010
    Figure 0007580076000010
  • Figure 0007580076000001
    Figure 0007580076000001
  • Figure 0007580076000002
    Figure 0007580076000002
Patent Text Reader

Abstract

To provide a cell culture apparatus and a cell culture method in which many cancer cells including a cancer cell that does not express EpCAM can be captured and cultured.SOLUTION: A cell culture apparatus in which a hydrophilic polymer layer is formed at least on a part of a surface of the apparatus, and fibronectin is adsorbed on the hydrophilic polymer layer. The hydrophilic polymer layer is formed of at least one type of hydrophilic polymer selected from a group consisting of [a], [b] and [c] below. [a] polymer having a specific structure, [b] poly(meth)acryloyl morpholine, and [c] a copolymer of at least one type of hydrophilic monomer selected from a group consisting of a compound having another specific structure (meth)acryloyl morpholine and another monomer.SELECTED DRAWING: None
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a cell culture device and a cell culture method capable of capturing and culturing specific cells in blood and body fluids (such as cancer cells present in blood and body fluids). [Background technology]

[0002] If we can capture and culture specific cells such as cancer cells, it is expected that this will be useful in elucidating the mechanisms of diseases, developing new drugs based on that knowledge, and examining treatment methods. In particular, it is known that once cancer cells develop, they eventually appear in the blood and body fluids, and cancer cells that appear in the blood are called circulating tumor cells (CTCs). It is expected that by examining these circulating tumor cells in the blood, it will be possible to confirm the effectiveness of cancer treatment, predict prognosis and life expectancy, predict the effectiveness of anticancer drugs before administration, and examine treatment methods using the genetic analysis of cancer cells.

[0003] However, the number of circulating tumor cells in the blood is very small (several to several hundred per 1 mL of blood), making it difficult to capture cancer cells and also difficult to culture and increase the number of captured cells.

[0004] For example, a technology known as the Cell Search system for capturing circulating tumor cells in the blood is known. However, because this is a technology that uses an antigen-antibody reaction (capture with EpCAM antibody), it can only capture cancer cells that express EpCAM, meaning there are limitations on the types of cancer cells that can be captured, and there are also limitations on culturing the captured cancer cells (see Patent Document 1, etc.). [Prior art documents] [Patent documents]

[0005] [Patent Document 1] Special Publication No. 2005-523981 Summary of the Invention [Problem to be solved by the invention]

[0006] The present invention aims to solve the above-mentioned problems and provide a cell culture device and a cell culture method that can capture and culture many cancer cells, including cancer cells that do not express EpCAM. [Means for solving the problem]

[0007] The present invention relates to a cell culture device having a hydrophilic polymer layer formed on at least a portion of the device surface and having fibronectin adsorbed onto the hydrophilic polymer layer, wherein the hydrophilic polymer layer is formed from at least one hydrophilic polymer selected from the group consisting of the following [a], [b], and [c]: [a] A polymer represented by the following formula (I): [ka] (In the formula, R 1 is a hydrogen atom or a methyl group, R 2 represents an alkyl group, m is 1 to 5, and n is the number of repetitions. [b] Poly(meth)acryloylmorpholine [c] A copolymer of at least one hydrophilic monomer selected from the group consisting of a compound represented by the following formula (I-1) and (meth)acryloylmorpholine, and another monomer: [ka] (In the formula, R 1 , R 2 , m is the same as above.)

[0008] In the cell culture device, the hydrophilic polymer layer preferably has a thickness of 10 to 800 nm. The cell culture apparatus is preferably an apparatus for culturing cells contained in blood or a body fluid.

[0009] The present invention also relates to a cell culture method comprising contacting a sample containing cells with a hydrophilic polymer layer to which fibronectin is adsorbed to capture and culture the cells, wherein the hydrophilic polymer layer is formed of at least one hydrophilic polymer selected from the group consisting of the following [a], [b], and [c]: [a] A polymer represented by the following formula (I): [ka] (In the formula, R 1 is a hydrogen atom or a methyl group, R 2 represents an alkyl group, m is 1 to 5, and n is the number of repetitions. [b] Poly(meth)acryloylmorpholine [c] A copolymer of at least one hydrophilic monomer selected from the group consisting of a compound represented by the following formula (I-1) and (meth)acryloylmorpholine, and another monomer: [ka] (In the formula, R 1 , R 2 , m is the same as above.)

[0010] In the cell culture method, it is preferable that the sample is brought into contact with the hydrophilic polymer layer to allow specific cells to adhere and / or adsorb thereto, and then the specific cells are cultured.

[0011] In the cell culture method, the sample is preferably at least one type selected from the group consisting of the following (1), (2) and (3). (1) Blood or body fluids (2) A sample in which specific cells in blood or body fluids are separated and / or concentrated from blood or body fluids (3) A sample in which specific cells in blood or body fluids are separated and / or concentrated from the blood or body fluids and then suspended

[0012] The separation and / or concentration is preferably carried out by cell size separation and / or centrifugation. It is preferable that the specific cells are separated and / or concentrated by the centrifugation using a separation liquid.

[0013] It is preferable to mix a hemolyzing agent with the sample during the separation and / or concentration. It is preferable to agglutinate blood cells in the sample during the separation and / or concentration.

[0014] In the above cell culture method, it is preferable to use a liquid medium for culture and to change the medium at least once every four days. Effect of the Invention

[0015] According to the present invention, a cell culture device is provided in which a hydrophilic polymer layer is formed on at least a portion of the device surface and fibronectin is adsorbed to the hydrophilic polymer layer, and the hydrophilic polymer layer is formed from at least one hydrophilic polymer selected from the group consisting of [a], [b] and [c].Therefore, the cell culture device is capable of capturing and culturing many cancer cells, including cancer cells that do not express EpCAM. [Brief description of the drawings]

[0016] [Figure 1] FIG. 2 is a schematic diagram of an example of a cell culture device having a fibronectin-adsorbing hydrophilic polymer layer formed on the inner surface. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0017] The present invention is a cell culture device having a hydrophilic polymer layer formed on at least a portion of the device surface and having fibronectin adsorbed onto the hydrophilic polymer layer, wherein the hydrophilic polymer layer is formed from at least one hydrophilic polymer selected from the group consisting of [a], [b] and [c].

[0018] Not only is a hydrophilic polymer layer formed on at least a portion of the surface of the cell culture device, but fibronectin is also adsorbed onto the hydrophilic polymer layer, which significantly improves the adhesion (adsorption) ability of the hydrophilic polymer to cells (specific cells such as cancer cells, etc.). This significantly improves the ability to capture specific cells such as cancer cells, while at the same time reducing the ability to capture platelets, etc., resulting in a selective capture effect for specific cells that cannot be achieved in a state with a large amount of protein. Furthermore, not only is a hydrophilic polymer layer formed on at least a portion of the surface of the cell culture device, but fibronectin is also adsorbed onto the hydrophilic polymer layer, which allows the captured cells (specific cells, etc.) to be cultured appropriately.

[0019] Specifically, the number of tumor cells (cancer cells, etc.) that appear in body fluids such as circulating tumor cells in the blood (several to several hundred cells / mL of blood) is very small, and it is important to capture as many tumor cells present in the collected body fluids as possible in order to provide them for testing. In the present invention, in addition to the hydrophilic polymer layer, fibronectin, which promotes adhesion (adsorption) of tumor cells, is further adsorbed to the surface of the hydrophilic polymer layer, so that by contacting this with body fluids such as blood, more tumor cells, etc. in the body fluid are adsorbed and adhered to the hydrophilic polymer layer. In addition, the presence of fibronectin promotes differentiation of the adsorbed and adhered tumor cells, and the culture proceeds. Then, by confirming the effectiveness of anticancer drugs, etc. with the cultured cells, the effectiveness of anticancer drugs, etc. can be confirmed outside the body before administration of anticancer drugs, and at the same time, it is useful for selecting anticancer drugs, etc. Furthermore, the cultured cells can be used to elucidate the mechanism of cancer cell proliferation and to develop new drugs (anticancer drugs, molecular targeted drugs, etc.).

[0020] Hereinafter, an example of a preferred embodiment of the present invention will be described with reference to the drawings. The cell culture device 1 in Fig. 1 is a device used for the purpose of capturing and culturing cells. Examples of the cells include specific cells such as cancer cells (any cancer cells including cancer cells that do not express EpCAM). Examples of the cancer cells include circulating tumor cells (CTCs).

[0021] The well 11 has a shape for injecting a solution containing cells into a well-shaped recess, capturing the cells, and then culturing the cells. The well 11 may be a single well or a multi-well (plate) in which wells are arranged in a matrix. The shape of the well is not particularly limited, and examples include a recess (recess) having a shape of a circle, an ellipse, a polygon such as a square, etc. Furthermore, the side wall of the well may be structured so as to be removable from the bottom. The well can be used to confirm (observe) the presence or absence of cells (specific cells, etc.), measure the number of cells (specific cell number, etc.), culture cells (specific cells, etc.), confirm and select the efficacy of a drug, etc. Furthermore, it may be easier to observe, measure, confirm and select, etc. if the side wall of the well is removable, and it is also easier to take out the cultured cells, etc.

[0022] The constituent material of the well 11 is preferably one that is highly transparent for cell observation, and examples of such materials include acrylic resins (polyacrylic resins) such as polymethyl acrylate, polymethyl methacrylate, polyacrylic acid, and polymethacrylic acid, cycloolefin resins (polycycloolefins), carbonate resins (polycarbonate), styrene resins (polystyrene), polyester resins such as polyethylene terephthalate (PET), polydimethylsiloxane, and glass (borosilicate glass, soda lime glass, etc.). For coating with a hydrophilic polymer, it is preferable that the constituent material is highly hydrophilic, and polyacrylic resin or soda lime glass is preferred.

[0023] Well 11 is a non-through hole with an opening at the top. A solution containing cells (a sample (blood, body fluid, etc. containing specific cells)) is injected into well 11 through the opening. In addition, when the presence of specific cells such as cancer cells is confirmed, it is also possible to inject a culture solution for culturing the specific cells.

[0024] The length L (each side when the opening is rectangular), diameter R (diameter when the opening is circular), and depth D of the opening of the well 11 are not particularly limited. From the viewpoint of putting a solution (sample), the depth D (height) is preferably 3 to 25 mm. In FIG. 1, the inner side of the well 11 is approximately perpendicular to the front and back surfaces of the well 11, but the well 11 may have an inclined inner side that narrows from the opening to the bottom. Also, the inner side may have an inclined inner side that widens from the opening to the bottom. Also, the bottom may be flat or uneven. Cells tend to gather in a concave depression, which is advantageous for culture. This is because a cluster of cells exchanges some kind of signal and culture is promoted more easily than a single cell.

[0025] In the case of a multi-well, the multiple wells may be separable. When multiple wells are provided, they can be used separately as a well for measuring the number of cells (specific cell count, etc.) and a well for culturing cells (specific cells, etc.), and for example, after confirming the presence or absence of cancer cells in the measurement well, if the presence is confirmed, the cancer cells can be cultured in the culture well and the efficacy of a drug can be confirmed using the cells.

[0026] In the cell culture device 1, a hydrophilic polymer layer 21 is formed on at least a portion of the surface of the device (the surface of the well 11), and fibronectin 31 is adsorbed to the hydrophilic polymer layer 21. In the case of the well 11, the surface of the device is preferably the inner surface. Fig. 1 shows an example in which a hydrophilic polymer layer 21 is formed on a portion of the bottom and side surfaces of the well 11, and fibronectin 31 is further adsorbed to the hydrophilic polymer layer 21.

[0027] When blood or body fluid is introduced into the well 11, specific cells such as cancer cells contained therein are adsorbed and adhered to the hydrophilic polymer layer 21 to which fibronectin 31 is adsorbed, while the adsorption of blood cells such as platelets is suppressed. Therefore, the specific cells can be adsorbed and adhered to the hydrophilic polymer layer 21 by holding the blood or body fluid for a predetermined time after introduction and then washing. Then, the number of adsorbed and adhered specific cells can be determined by measuring the number of adsorbed and adhered specific cells. Furthermore, since the specific cells are adsorbed and adhered to the hydrophilic polymer layer to which fibronectin is also adsorbed, the specific cells can be efficiently cultured. Therefore, by using the cultured specific cells, it is expected that the effectiveness of cancer treatment can be confirmed.

[0028] The thickness of the hydrophilic polymer layer 21 (layer formed of a hydrophilic polymer) is preferably 10 to 800 nm, more preferably 30 to 550 nm. By adjusting the thickness within the above range, good low adsorption to proteins and cells, and selective adsorption and adhesion to cancer cells can be obtained. In addition, cancer cells can be efficiently cultured.

[0029] The hydrophilic polymer forming the hydrophilic polymer layer 21 is at least one type selected from the group consisting of the following [a], [b], and [c]. [a] A polymer represented by the following formula (I): [ka] (In the formula, R 1 is a hydrogen atom or a methyl group, R 2 represents an alkyl group, m is 1 to 5, and n is the number of repetitions. [b] Poly(meth)acryloylmorpholine [c] A copolymer of at least one hydrophilic monomer selected from the group consisting of a compound represented by the following formula (I-1) and (meth)acryloylmorpholine, and another monomer: [ka] (In the formula, R 1 , R 2 , m is the same as above.)

[0030] In formula (I) and (I-1), R 2 The number of carbon atoms in the alkyl group of R is preferably 1 to 10, and more preferably 1 to 5. 2 is particularly preferably a methyl group or an ethyl group. m is preferably an integer of 1 to 3. n (the number of repeating units) is preferably an integer of 15 to 1,000, and more preferably an integer of 30 to 500.

[0031] In the copolymer [c], the other monomers may be appropriately selected within a range that does not inhibit the action and effect of the hydrophilic polymer, such as aromatic monomers such as styrene, vinyl acetate, and N-isopropylacrylamide that can impart temperature responsiveness.

[0032] From the viewpoints of selective adsorptivity and adhesiveness to cancer cells and culturability of cancer cells, the number average molecular weight (Mn) of the hydrophilic polymer is preferably 8,000 to 150,000, more preferably 10,000 to 60,000, and even more preferably 12,000 to 50,000. In this specification, Mn can be determined in terms of standard polystyrene based on measurements obtained by gel permeation chromatography (GPC) (GPC-8000 series manufactured by Tosoh Corporation, detector: differential refractometer, column: TSKGEL SUPERMALTPORE HZ-M manufactured by Tosoh Corporation).

[0033] It is preferable to use a solution, dispersion, or the like in which the fibronectin concentration is adjusted to preferably 0.5 to 500 μg / ml, more preferably 1 to 250 μg / ml, in order to adsorb fibronectin 31 onto the hydrophilic polymer layer 21. By adjusting the concentration within the above range, good low adsorption to proteins and cells, selective adsorption and adhesion to cancer cells, and culturability of cancer cells can be obtained.

[0034] The cell culture device 1 can be manufactured, for example, by adding a well 11 having a hydrophilic polymer layer 21 with fibronectin 31 adsorbed on the inner surface thereof as shown in Figure 1, a multi-well plate having multiple wells 11, and further adding other members (components) as necessary.

[0035] Specifically, in the case of a device having a well 11 in which a hydrophilic polymer layer 21 is formed, a well 11 in which a polymer layer formed from a hydrophilic polymer is formed can be manufactured by coating all or part of the inner surface of the well 11 with a hydrophilic polymer solution or dispersion using known techniques, such as (1) a method of injecting a hydrophilic polymer solution or dispersion, in which a hydrophilic polymer is dissolved or dispersed in various solvents, into the inside of the well 11 and holding the solution for a predetermined period of time, or (2) a method of applying (spraying) the hydrophilic polymer solution or dispersion onto the inner surface of the well 11.

[0036] As the solvent, injection method, coating (spraying) method, and the like, conventionally known materials and methods can be used. The retention times for (1) and (2) may be appropriately set depending on the size of the well 11, the type of liquid to be introduced, etc., but are preferably 5 minutes to 10 hours, more preferably 10 minutes to 5 hours, and even more preferably 15 minutes to 2 hours. After retention, the excess hydrophilic polymer solution / dispersion may be drained as appropriate, or may be dried without being drained.

[0037] Next, the method for adsorbing fibronectin 31 to the formed hydrophilic polymer layer 21 is not particularly limited, and known methods can be applied. For example, the hydrophilic polymer layer 21 can be adsorbed by contacting it with a buffer solution of fibronectin 31 (phosphate buffered saline, PBS, etc.) using a known method, leaving it at a predetermined temperature for a predetermined time, and washing as necessary. The temperature and time can be appropriately set, and can be performed, for example, at 10 to 50°C for about 0.1 to 24 hours.

[0038] The hydrophilic polymer layer 21 having the fibronectin 31 adsorbed thereon is then formed on a portion of the inner surface of the well 11, and other components are added as necessary to produce a cell culture device.

[0039] The cell culture method of the present invention is a cell culture method in which a sample containing cells (such as blood or body fluid containing specific cells) is brought into contact with a hydrophilic polymer layer to capture and culture the cells, and the hydrophilic polymer layer is formed from at least one hydrophilic polymer selected from the group consisting of [a], [b], and [c].

[0040] As described above, the cell culture device improves the capturing ability of cancer cells, etc., while decreasing the capturing ability of blood cells such as platelets, thereby obtaining a selective capturing effect of cancer cells, etc., and further enabling efficient culturing of cancer cells, etc. Therefore, for example, by using the device, blood or body fluid (a sample containing cells) is brought into contact with a hydrophilic polymer layer to which fibronectin is adsorbed, thereby adhering and / or adsorbing specific cells such as cancer cells, and then culturing the specific cells, and examining the cultured specific cells, it is expected that the aforementioned effects of cancer treatment can be confirmed, the effectiveness of anticancer drugs, etc. outside the body can be confirmed, anticancer drugs, etc. can be selected, new drugs can be developed, and the mechanisms of diseases can be elucidated, etc.

[0041] Suitable samples that contain cells include (1) blood or body fluids (blood itself or body fluids themselves), (2) samples in which specific cells in the blood or body fluids have been separated and / or concentrated from blood or body fluids, and (3) samples in which specific cells in the blood or body fluids have been separated and / or concentrated from blood or body fluids and then suspended, etc.

[0042] In the above (2) and (3), the separation and / or concentration of specific cells such as cancer cells can be carried out by separation and concentration based on the size of the cells, separation and concentration by centrifugation, etc. Examples of separation and concentration based on the size of the cells include methods using filters, etc.

[0043] The centrifugation can be performed by a known method, for example, by using a known centrifuge. The centrifugal force, centrifugation time, and temperature in the centrifugation may be appropriately set in view of the separation of blood cells, cancer cells, etc. By subjecting the collected blood or body fluid to centrifugation and separating the intermediate mononuclear cell layer, platelets, red blood cells, and polynuclear white blood cells are separated and removed, and a sample with an increased concentration of specific cells such as cancer cells can be prepared.

[0044] Before centrifugation, other treatments may be performed to reduce the protein concentration in blood or body fluids. Examples of other treatments to reduce the protein concentration in blood or body fluids include diluting the collected blood or body fluids. Here, the dilution method includes a method using a buffer solution such as phosphate buffered saline (PBS) with a pH of human blood (about 7.4) or a liquid medium such as DMEM (Dulbecco's modified Eagle medium). Specifically, the protein concentration can be reduced compared to that of the collected blood or body fluids by adding a buffer solution to the collected blood or body fluids or by adding the collected blood or body fluids to a liquid medium to dilute the collected blood or body fluids.

[0045] In the centrifugation, it is preferable to separate and / or concentrate the specific cells by centrifugation using a separation liquid. This allows suitable separation into a mononuclear cell layer containing specific cells (cancer cells, etc.), a layer containing red blood cells, etc. Then, the mononuclear cell layer is separated, and the specific cells in the layer are captured in a hydrophilic polymer layer to which fibronectin is adsorbed, and then cultured, whereby the specific cells can be suitably cultured.

[0046] The separation liquid used in density gradient centrifugation may be prepared so as to have a specific gravity suitable for fractionating cells in blood and an osmotic pressure and pH that do not destroy cells. As the medium, a medium that can be used in density gradient centrifugation can be used. The separation liquid preferably has a specific gravity of 1.076 to 1.078 g / ml at 20° C. The pH of the separation liquid is preferably 4.5 to 7.5.

[0047] Representative media (separation solutions) include sucrose, Ficoll (a copolymer of sucrose and epichlorohydrin), and Percoll (a colloidal silica product coated with polyvinylpyrrolidone). Ficoll products include Ficoll-Paque PLUS (Pharmacia Biotech), Histopaque-1077 (Sigma-Aldrich Japan), and Lymphoprep (Nycomed, Oslo, Norway); Percoll products include Percoll (Sigma-Aldrich Japan).

[0048] In the above (3), the suspension treatment can be carried out using a method that uses a liquid medium, or the like.

[0049] In the above (2) and (3), it is preferable to mix (add) a hemolytic agent to the sample when isolating and / or concentrating specific cells, because this allows at least a portion of the red blood cells in the sample to be removed. A hemolytic agent is a reagent that acts physically or chemically on red blood cells to dissolve them. As the hemolytic agent, a conventionally used one can be used, and examples of the hemolytic agent include ammonium chloride, synthetic surfactants, and alcohols.

[0050] In the above (2) and (3), it is preferable to cause blood cells to aggregate in a sample when isolating and / or concentrating specific cells. The method for agglutinating blood cells is not particularly limited as long as it is a method capable of causing such agglutination, and among them, a method utilizing an antigen-antibody reaction is preferably used. Specifically, an agglutination reaction method such as a hemagglutination reaction is preferably used.

[0051] In such an agglutination step, cells are agglutinated in blood or body fluid using a hemagglutination reaction, and then when the sample containing the agglutinates is centrifuged, the agglutinates containing blood cells are removed. Therefore, specific cells (such as cancer cells) remaining in high concentrations in the sample can be effectively captured by the hydrophilic polymer layer.

[0052] For the aggregation of blood cells, for example, a method of mixing (adding) a compound that aggregates blood cells can be used. Specifically, a red blood cell and white blood cell agglutinating antibody reagent (red blood cell and white blood cell agglutinating antibody composition) can be used. During centrifugation, separation of some white blood cells, which have a specific gravity close to that of specific cells such as cancer cells, becomes poor. However, by using the above antibody composition to bind and aggregate red blood cells and white blood cells using an antigen-antibody reaction, separation of not only red blood cells and platelets, which have a different specific gravity from the specific cells, but also white blood cells and the specific cells becomes good, and adhesion and capture of the specific cells are improved.

[0053] In the cell culture method, the method of contacting a sample containing cells with a hydrophilic polymer layer to which fibronectin is adsorbed to capture the cells can be any method that allows the sample to come into contact with the hydrophilic polymer layer. For example, when using an apparatus having a well on which a hydrophilic polymer layer is formed, a method of injecting a sample into the inside of the well can be mentioned. After contact (injection), the cells can be captured (adsorbed, adhered) to the hydrophilic polymer layer by maintaining the sample under a predetermined condition. The predetermined condition can be appropriately set, and can be, for example, maintained at 34 to 40°C for 10 minutes to 15 hours.

[0054] In the cell culture method, the method for culturing the captured cells may be appropriately adopted. For example, the cells can be suitably cultured by adding a liquid medium to the fibronectin-adsorbed hydrophilic polymer layer on which cells such as specific cells are captured, and maintaining the liquid medium under a predetermined condition. The predetermined condition may be appropriately set, and may be maintained, for example, at 34 to 40° C. for 1 to 10 weeks.

[0055] In the cell culture method, it is preferable to use a liquid medium for culture and to change the medium at least once every four days, thereby enabling the culture of specific cells or other cells to be carried out in an optimal manner. EXAMPLES

[0056] The present invention will be specifically described based on examples, but the present invention is not limited to these examples.

[0057] Example 1 Using AIBN (azobisisobutyronitrile), 2-methoxyethyl acrylate was thermally polymerized at 80°C for 6 hours to produce poly(2-methoxyethyl acrylate) (molecular weight Mn: approximately 15,000, Mw: approximately 50,000). A 2.5 W / V% methanol solution of the obtained poly(2-methoxyethyl acrylate) was then prepared. The prepared poly (2-methoxyethyl acrylate) solution (2.5 W / V%) was poured into a commercially available PMMA plate (depth D (height) 17.5 mm) and left at room temperature for 30 minutes. The liquid was then sucked out with a pipette and dried to prepare a hydrophilic polymer layer. Furthermore, fibronectin was adsorbed onto the portion coated with poly(2-methoxyethyl acrylate) (hydrophilic polymer layer). Specifically, a 100 μg / ml fibronectin solution in PBS (phosphate buffered saline) was prepared, left at 40°C for 1 hour, and then washed with PBS solution to produce a cell culture device having a multi-well plate on which a fibronectin-adsorbed hydrophilic polymer layer was formed, as shown in Figure 1.

[0058] Example 2 A cell culture device was produced in the same manner as in Example 1, except that the material was changed to poly (2-methoxyethyl acrylate) (molecular weight Mn: about 30,000, Mw: about 95,000).

[0059] Example 3 Using AIBN (azobisisobutyronitrile), 2-methoxyethyl acrylate was thermally polymerized at 80°C for 6 hours to produce poly(2-methoxyethyl acrylate) (molecular weight Mn: approximately 15,000, Mw: approximately 50,000). A 0.25 W / V% methanol solution of the obtained poly(2-methoxyethyl acrylate) was then prepared. The prepared poly (2-methoxyethyl acrylate) solution (0.25 W / V%) was injected into a commercially available chamber slide (two-chamber type, with the chamber on the side of the well removable, the bottom made of a glass substrate (soda-lime glass), and the depth D (height) was 12 mm), and the slide was left at room temperature for 5 minutes and then vacuum-dried at 40°C to prepare a hydrophilic polymer layer. Furthermore, fibronectin was adsorbed onto the portion coated with poly (2-methoxyethyl acrylate) (hydrophilic polymer layer). Specifically, a 200 μg / ml fibronectin solution in PBS (phosphate buffered saline) was prepared, left at 40°C for 1 hour, and then washed with PBS solution to produce a cell culture device with a fibronectin-adsorbed hydrophilic polymer layer formed, as shown in Figure 1.

[0060] Example 4 A cell culture device was produced in the same manner as in Example 3, except that the material was changed to poly (2-methoxyethyl acrylate) (molecular weight Mn: about 30,000, Mw: about 95,000).

[0061] Comparative Example 1 A commercially available chamber slide (two-chamber type, with the chamber on the side of the well section removable and the bottom made of glass (soda-lime glass)) was used.

[0062] Comparative Example 2 Fibronectin was adsorbed onto a commercially available chamber slide (two-chamber type, with the chambers on the sides of the wells removable and the bottom made of a glass substrate (soda-lime glass)). Specifically, a 200μg / ml fibronectin solution in PBS (phosphate buffered saline) was prepared, left at 40℃ for 1 hour, and then washed with PBS solution to produce a cell culture device with a fibronectin adsorption layer formed.

[0063] The cell culture devices prepared in the examples and comparative examples were evaluated by the following method.

[0064] [Film thickness of hydrophilic polymer layer (coating layer)] The thickness of the hydrophilic polymer layer on the inner surface of the well was measured (photographed) using a TEM at an accelerating voltage of 15 kV and 1000x magnification.

[0065] [Spiked blood test in which cancer cells were added to whole blood: measuring the number of adherent cells] Stained human colon cancer-derived epithelial cells (HT-29) were suspended in whole blood at 100 cells / mL of blood (spiked blood). An equal amount of liquid medium was added to dilute this (diluted spiked blood). Next, a separation solution (LymphoPrep: density 1.077±0.001g / mL) was placed in a 15mL centrifuge tube, and the diluted spiked blood was placed on top of it and centrifuged at 800g for 20 minutes. The mononuclear cell layer was then separated. A phosphate buffered saline (PBS) solution was added to the separated mononuclear cell layer, and the mixture was centrifuged again to concentrate it. The mass formed at the bottom layer after centrifugation was suspended in liquid medium containing 10% FBS (fetal bovine serum) (the same amount of liquid as the initial whole blood volume). 1mL of this suspension was injected into the wells and allowed to adhere at 37°C for 1 hour. After that, the unadhered cells were washed with PBS solution. The number of attached cancer cells was then counted using a fluorescent microscope. The number of adherent cancer cells in Comparative Example 1 was set at 1.00, and the comparison was made using relative values.

[0066] [Spiked blood test in which cancer cells were added to whole blood: Counting the number of cultured cells] Human colon cancer-derived epithelial cells (HT-29) (unstained) were suspended in whole blood at 100 cells / mL of blood (spiked blood). An equal amount of liquid medium was added to dilute this (diluted spiked blood). Next, a separation solution (LymphoPrep: density 1.077±0.001g / mL) was placed in a 15mL centrifuge tube, and the diluted spiked blood was placed on top of it, and centrifugation was performed at 800g for 20 minutes. The mononuclear cell layer was then separated. A phosphate buffered saline (PBS) solution was added to the separated mononuclear cell layer, and centrifugation was performed again to concentrate it. The mass formed at the bottom layer after centrifugation was suspended in liquid medium (the same amount of liquid as the initial whole blood volume) with 10% FBS (fetal bovine serum). 1ml of this suspension was injected into the wells and allowed to adhere at 37°C for 1 hour. After that, unadhered cells were washed with PBS solution. Next, liquid medium was added and the cells were cultured at 37°C for 3 weeks. The liquid medium was replaced once every two days during the culture. After the incubation, the cells were detached with trypsin and counted using a hemocytometer. The increase in the number of cultured cancer cells in Comparative Example 1 was set at 1.00, and the results were compared as relative values.

[0067] [Table 1]

[0068] In Examples 1 to 4, in which a hydrophilic polymer layer with fibronectin adsorbed thereon was formed, the amount of cancer cells adhered was significantly improved compared to Comparative Example 1. This was presumably because fibronectin, a protein related to the adhesion of cancer cells, was adsorbed onto the poly (2-methoxyethyl acrylate) layer, allowing the cancer cells to adhere preferentially.

[0069] In Examples 1 to 4, in which a hydrophilic polymer layer with fibronectin adsorbed thereon was formed, the number of cells increased by the culture of cancer cells was significantly improved compared to Comparative Example 1. This was presumably because the culture of cancer cells was promoted because fibronectin, a protein related to the adhesion and promotion of cancer cell culture, was adsorbed onto the poly (2-methoxyethyl acrylate) layer. [Explanation of symbols]

[0070] 1 Cell culture device 11 wells 21 Hydrophilic polymer layer 31 Fibronectin

Claims

1. A method for culturing cancer cells, comprising: bringing a sample containing cancer cells into contact with a hydrophilic polymer layer having fibronectin adsorbed thereon to capture the cancer cells; adding a liquid medium to the hydrophilic polymer layer; and maintaining the liquid medium at 34 to 40° C. for 1 to 10 weeks to culture the cancer cells, The hydrophilic polymer layer is formed of at least one hydrophilic polymer selected from the group consisting of the following [a], [b], and [c]: [a] A polymer represented by the following formula (I): 【Chemistry 1】 (In the formula, R 1 is a hydrogen atom or a methyl group, R 2 represents an alkyl group, m is 1 to 5, and n is the number of repetitions.) [b] Poly(meth)acryloylmorpholine [c] A copolymer of at least one hydrophilic monomer selected from the group consisting of a compound represented by the following formula (I-1) and (meth)acryloylmorpholine, and another monomer: 【Chemistry 2】 (In the formula, R 1 , R 2 , m is the same as above.) The sample is at least one selected from the group consisting of the following (1) and (2): (1) A sample in which cancer cells in blood or body fluid are separated and / or concentrated from blood or body fluid (2) A sample in which cancer cells in blood or body fluid are separated and / or concentrated from the blood or body fluid and then suspended A cancer cell culture method in which blood cells in the sample are agglutinated by utilizing an antigen-antibody reaction during the separation and / or concentration.

2. The method for culturing cancer cells according to claim 1 , wherein the separation and / or concentration is carried out by separation based on the size of the cells and / or by centrifugation.

3. The method for culturing cancer cells according to claim 2 , wherein the cancer cells are separated and / or concentrated by the centrifugation using a separation liquid.

4. The method for culturing cancer cells according to any one of claims 1 to 3, wherein a hemolytic agent is mixed with the sample during the separation and / or concentration.

5. The method for culturing cancer cells according to any one of claims 1 to 4, wherein the culture medium is changed at least once every four days.

Citation Information

Patent Citations

  • Compositions and methods for enriching white blood cells from human whole blood

    JP1996510322A

  • Coating compositions for hydrophilic multi-use

    JP2005523981A

  • Synthetic surface for culturing cells in a culture medium of known composition

    JP2011510655A

  • System and method for separating cells from body fluids

    JP2012510271A

  • Cell isolation methods

    JP2014533957A